Prospects and Moral Implications of Genetic Alteration in Human Polygenes

Prospects and Moral Implications of Genetic Alteration in Human Polygenes

In the rapidly evolving field of genomic medicine, a promising new approach known as heritable polygenic editing has caught the attention of scientists, policymakers, and ethicists worldwide. This method, which involves modifying multiple genetic variants simultaneously, holds the potential to significantly reduce the prevalence of complex diseases such as Alzheimer's, schizophrenia, type 2 diabetes, and coronary artery disease. However, as a recent analysis published in *Nature* outlines, the current ethical implications and societal concerns surrounding this technology are multifaceted and deeply debated.

One of the primary concerns is the risk of eugenics and social inequality. The possibility of selecting embryos for perceived "positive" traits (like intelligence, athletic ability, or appearance) could revive eugenic ideologies, creating societal divides where only affluent families can afford to select "superior" genetic traits. This could exacerbate existing social inequalities and lead to discrimination based on genetics, with economically privileged groups gaining unfair advantages.

Another concern is the potential mental and emotional harm that could result from such selections. The pressure on children born from such selections to meet heightened expectations may cause emotional and mental health issues, including increased risk for mental diseases or even mortality associated with the psychological burdens of living up to idealized traits.

Safety and medical necessity are also significant concerns. Many scientific and biotech organizations call for a moratorium or ban on heritable genome editing due to concerns over safety, lack of clear medical need, and ethical risks. The technology remains mostly prohibited by policies worldwide, with broad support for keeping heritable editing legally off limits to prevent irresponsible use and unforeseen consequences.

Commercialization and rogue actors pose additional challenges. Despite widespread regulatory prohibitions, some tech billionaires and privately funded companies are seeking to commercialize the technology to create genetically edited babies, raising concerns about unregulated practices and ignoring ethical, societal, and safety risks.

Global inequalities and indigenous rights are also a concern. There is concern about ongoing inequalities in genomic research and use, particularly regarding how genetic data and biological samples from marginalized or indigenous populations are used without proper consent or benefit to those communities. This raises questions about data ownership, secondary use, and the ethical conduct of research in global contexts.

Behavioral genetics misuse is another area of concern. There is caution against misuse of polygenic and behavioral genetics research, which could reinforce stereotypes or justify discriminatory practices if misunderstood or applied without careful ethical considerations.

Experts stress the need for equitable access, robust regulatory governance, and ongoing ethical scrutiny to balance technological innovation in IVF and genomic medicine with social responsibility and the welfare of future generations. As we move forward, it is crucial to foster an informed dialogue that considers both the scientific possibilities and ethical responsibilities inherent in altering human genetics.

In sum, the ethical and societal concerns center on issues of equity, consent, safety, social justice, the risk of discrimination and eugenics, potential psychological harm, and the need for strict regulatory frameworks to govern the responsible use of heritable polygenic editing in genomic medicine. Societies should engage in discussions about the implications of heritable polygenic editing to ensure a balanced approach that protects both the potential benefits and the ethical standards that promote equity and protect against misuse.

[1] Smith, J. (2021). Ethical implications of heritable polygenic editing in genomic medicine. Nature Reviews Genetics, 22(1), 8-17. [2] Jones, M. (2020). The ethical landscape of heritable genome editing. Nature Reviews Genetics, 21(12), 782-793. [3] Racimo, F., et al. (2019). Genomic data and global health disparities. Cell, 178(7), 1517-1532. [4] Kahn, J. (2019). The ethical implications of polygenic risk scores. Nature Genetics, 51(8), 1069-1070. [5] National Academy of Sciences, Engineering, and Medicine. (2017). Human gene editing: Science, ethics, and governance. Washington, DC: National Academies Press.

1. The concern of eugenics and social inequality arises due to the possibility of selecting embryos for perceived "positive" traits, which could potentially exacerbate existing social inequalities and lead to discrimination based on genetics.
2. Safety and medical necessity are significant concerns surrounding heritable genome editing, as many scientific and biotech organizations call for a moratorium or ban on such editing due to concerns over safety, lack of clear medical need, and ethical risks.
3. Global inequalities and indigenous rights are a concern in genomic medicine, particularly regarding how genetic data and biological samples from marginalized or indigenous populations are used without proper consent or benefit to those communities, raising questions about data ownership, secondary use, and the ethical conduct of research in global contexts.

Read also: